Research Article
Designing Peptide-Based HIV Vaccine for Chinese
Table 3
Using novel algorism to calculate the coverage of epitopes in a published T helper vaccine for Chinese population.
| Amino acid sequence | Protein destination1 | HIV%2 | DR%3 | Specific coverage4 |
| FRKYTAFTIPSINNE | Pol 303 | 14% | 98% | 13% | EKVYLAWVPAHKGIG | Pol 711 | 3% | 98% | 3% | GEIYKRWIILGLNKI | Gag 294 | 20% | 87% | 18% | KRWIILGLNKIVRMY | Gag 298 | 43% | 89% | 41% | GAVVIQDNSDIKVVP | Pol 989 | 21% | 57% | 12% | YRKILRQRKIDRLID | Vpu 31 | 2% | 89% | 2% | QKQITKIQNFRVYYR | Pol 956 | 19% | 98% | 19% | SPAIFQSSMTKILEP | Pol 335 | 11% | 93% | 11% | QHLLQLTVWGIKQLQ | Env 729 | 23% | 83% | 21% | AETFYVDGAANRETK | Pol 619 | 7% | 41% | 2% | QGQMVHQAISPRTLN | Gag 171 | 3% | 85% | 3% | WAGIKQEFGIPYNPQ | Pol 874 | 3% | 35% | 1% | KVYLAWVPAHKGIGG | Pol 712 | 3% | 93% | 2% | KTAVQMAVFIHNFKR | Pol 915 | 24% | 83% | 22% | EVNIVTDSQYALGII | Pol 674 | 24% | 57% | 16% | WEFVNTPPLVKLWYQ | Pol 596 | 22% | 91% | 22% | HSNWRAMASDFNLPP | Pol 758 | 11% | 57% | 7% |
| Total specific coverage5 | | | | 69% |
|
|
The epitopes were selected from a published paper. Data in columns 2–5 were calculated using the same method as in Table 2.
|